Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
P JungersN K Man

Abstract

Accelerated atherosclerosis resulting in an abnormally high incidence of coronary and cerebrovascular occlusive accidents has been repeatedly reported in dialysis patients, but incidence and risk factors of such complications in chronic renal failure (CRF) predialysis patients are debated. We prospectively assessed the incidence of first myocardial and cerebral infarction episodes in a cohort of 147 CRF patients (99 male) followed from January 1985 to December 1994. Relevant clinical and laboratory risk factors for atherogenesis were determined at yearly intervals. They included blood pressure, smoking, blood lipids, fibrinogen, and homocysteine which were compared in patients with (CVA+) or without (CVA-) occurrence of cardiovascular (CV) atherosclerotic accidents. Incidence of CV accidents was nearly three times higher in CRF patients than in the French general population in both genders. In particular, incidence of myocardial infarction in male patients aged 45-55, 55-65 and > 65 years was 7.6, 18.2, and 27.8/1000 patient-years, respectively, compared to 3.4, 8.9, and 10.4/1000 subject-years in the general population. Although age and degree of renal failure at onset of CV events or at end of follow-up did not differ between...Continue Reading

Citations

Jan 1, 2003·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·GianCarlo MarenziIvana Marana
Nov 6, 2012·Molecular and Cellular Biochemistry·Alvaro OsorioEstrella Ruiz-Requena
Nov 6, 2010·Current Atherosclerosis Reports·Abhishek Deshmukh, Jawahar L Mehta
Jul 1, 2008·Indian Journal of Clinical Biochemistry : IJCB·Pragna RaoA S Kanagasabapathy
Jun 30, 2007·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Omer Aras, Vasken Dilsizian
Nov 7, 2000·The American Journal of Medicine·C CatenaL A Sechi
May 29, 2002·Thrombosis Research·Majdi M Abdel-RaheemByron D Danielson
Jun 28, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Vandana MenonMark J Sarnak
Aug 22, 2009·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Michinari NakamuraTadanori Aizawa
Aug 5, 1999·Kidney International·T Nguyen-KhoaB Descamps-Latscha
Oct 10, 2002·Kidney International·Srinivasan BeddhuJeffrey L Anderson
Sep 13, 2003·Kidney International·Berthil H C M T PrinsenMonique G M De Sain-Van Der Velden
Mar 13, 2003·Kidney International·Stephan R Orth, Dominik E Uehlinger
Apr 16, 2003·Kidney International. Supplement·Robert ClarkeMartin Landray
Oct 9, 2003·Kidney International. Supplement·Madhumathi Rao, Brian J G Pereira
Mar 5, 2002·Seminars in Dialysis·Raymond VanholderGerrit Lesaffer
Mar 29, 2003·Artificial Organs·Tatsuya NakataniKazunobu Sugimura
Sep 17, 1998·The New England Journal of Medicine·R G Luke
Oct 3, 2003·The New England Journal of Medicine·Giancarlo MarenziAntonio L Bartorelli
Oct 28, 2004·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Muriel P C Grooteman, Menso J Nubé
Apr 9, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·R VanholderUNKNOWN European Uremic Toxin Work Group
Sep 29, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Muriel P C GrootemanMenso J Nubé
Apr 1, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Alexander S Goldfarb-RumyantzevAnna Barenbaum
Feb 24, 2001·Journal of Hypertension·C ZoccaliF Tassone
Dec 30, 1998·Current Opinion in Lipidology·H Refsum, P M Ueland
Aug 24, 1999·Current Opinion in Nephrology and Hypertension·R M Brenner, E M Wrone
Sep 16, 2000·Current Opinion in Nephrology and Hypertension·C KitiyakaraC S Wilcox
Feb 22, 2002·Current Opinion in Nephrology and Hypertension·Surekha MathurIshwarlal Jialal
Sep 9, 2005·Journal of Hypertension·Susan M HailpernMichael H Alderman
Apr 30, 2003·Transplantation·Herwig-Ulf Meier-KriescheBruce Kaplan
Sep 18, 2002·Kidney International·Ronald M A HenryCoen D A Stehouwer
Feb 12, 2004·Kidney International·Berthil H C M T PrinsenMonique G M de Sain-van der Velden
Jun 18, 2004·Kidney International·Madhumathi RaoUNKNOWN HEMO Study Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.